Edition:
United Kingdom

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

22.78USD
6:01pm GMT
Change (% chg)

$-0.72 (-3.06%)
Prev Close
$23.50
Open
$23.50
Day's High
$23.73
Day's Low
$22.58
Volume
43,456
Avg. Vol
137,525
52-wk High
$46.12
52-wk Low
$19.72

Chart for

About

Audentes Therapeutics, Inc. is an early-stage biotechnology company. The Company is focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects. The Company has a portfolio of product candidates, including AT132 for the... (more)

Overall

Beta: --
Market Cap(Mil.): $722.67
Shares Outstanding(Mil.): 27.78
Dividend: --
Yield (%): --

Financials

  BOLD.OQ Industry Sector
P/E (TTM): -- 85.49 33.64
EPS (TTM): -3.54 -- --
ROI: -57.99 -0.29 14.22
ROE: -145.70 0.40 15.99

BRIEF-Audentes Announces Data From First Dose Cohort Of ASPIRO

* AUDENTES ANNOUNCES CONTINUING POSITIVE DATA FROM FIRST DOSE COHORT OF ASPIRO, A PHASE 1/2 CLINICAL TRIAL OF AT132 IN PATIENTS WITH X-LINKED MYOTUBULAR MYOPATHY

16 May 2018

Earnings vs. Estimates